Immunology in the liver — from homeostasis to disease

被引:0
作者
Felix Heymann
Frank Tacke
机构
[1] RWTH University-Hospital Aachen,Department of Medicine III
来源
Nature Reviews Gastroenterology & Hepatology | 2016年 / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The liver is a central immunological organ with a high density of myeloid (such as Kupffer cells, neutrophils or macrophages) and lymphoid (such as natural killer cells, T cells or B cells) immune cellsAs antigen-rich blood from the gastrointestinal tract and gut-derived endotoxins pass through the sinusoids, many mechanisms in homeostasis ensure suppression of innate and adaptive immune responses, resulting in toleranceIn conditions of hepatic diseases, conserved mechanisms such as molecular danger patterns (alarmins), Toll-like receptor signalling or inflammasome activation initiate inflammatory responses, resulting in the chemokine-mediated hepatic infiltration of circulating leukocytesKupffer cells and monocyte-derived macrophages adapt their phenotype to local signals and exert critical functions in perpetuating inflammation and wound healing, but can also mediate resolution of inflammation and fibrosisInnate lymphocytes (for example, natural killer and natural killer T cells) are another source of immunoregulatory cytokines in diseased livers and furthermore contribute to eliminating activated myofibroblasts and infected, injured or malignant cellsThe heterogeneous pool of hepatic T cells is activated towards immunity upon injury, resulting in immune-stimulatory cytokine secretion as well as direct cytopathic functions, especially in viral and autoimmune hepatitis
引用
收藏
页码:88 / 110
页数:22
相关论文
共 429 条
  • [91] von Oppen N(2014)IL-33 — a cytokine which balances on a knife's edge? Nature 513 59-579
  • [92] Tuncer C(2009)Inflammasomes: mechanism of action, role in disease, and therapeutics Gut 58 704-1518
  • [93] Oo YH(2005)The inflammasomes: guardians of the body Hepatology 42 193-196
  • [94] Murphy N(2003)Sterile inflammation in the liver Hepatology 37 1043-1517.e10
  • [95] Adams DH(2005)The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β J. Immunol. 175 1643-314
  • [96] Lalor PF(2013)The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Hepatology 58 374-569
  • [97] Crispe IN(2007)ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury J. Hepatol. 47 571-1817
  • [98] Schildberg FA(2011)Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury Alcohol. Clin. Exp. Res. 35 1509-344
  • [99] Winau F(2014)Intravascular danger signals guide neutrophils to sites of sterile inflammation Liver Int. 34 184-1126
  • [100] Weiskirchen R(2014)Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity J. Transl. Med. 12 129-286